Arcade Therapeutics and Kean University Offer Game-Based Digital Therapeutic to College Students with Social Anxiety

Arcade and Kean will launch a separate research study to investigate the impact of StarStarter Rx on student mental health. Arcade Therapeutics jointly announced a partnership with Kean University’s Counseling Center to offer students StarStarter Rx, a therapeutic mobile game designed to reduce social anxiety. Kean will offer free access to Arcade’s digital therapeutic as part of a broader initiative to expand its facilities and mental health resources. “Social anxiety can be debilitating to students’ lives by encouraging avoidant behavior through excessive rumination and worry. It can be the obstacle to joining an extracurricular activity, having fun with friends, or raising your hand in class…

Arcade Therapeutics and UT Austin Jointly Announce a $3.8M NIMH Grant to Fund Large Clinical Trial Testing the Efficacy of ABM-02, The First Game-Based Digital Therapeutic for Major Depressive Disorder

The R01 Grant from the National Institute of Health, consisting of $3.8M in funding to UT Austin’s Institute for Mental Health Research, was recently approved with a kickoff date of September 1st. Arcade Therapeutics and University of Texas Austin’s Institute for Mental Health Research jointly announced the closing of a $3.8M grant from the National Institute for Mental Health (NIMH) to support clinical investigation and validation of ABM-02 as a game-based treatment for Major Depressive Disorder (MDD)…

Clinical Trial of Arcade Therapeutics’ Flagship Therapeutic Mobile Game, StarStarter Rx, Shows Robust Reductions in Social Anxiety in Adults

Arcade Therapeutics (fka Wise Therapeutics) announced topline results of their StarStarter Rx Pilot Study, evaluating the efficacy and safety of their flagship digital therapeutic in adults 22-65 with Social Anxiety Disorder (SAD). The study achieved its predefined efficacy outcome for its primary endpoint, the Liebowitz Social Anxiety Scale (LSAS), as well as secondary and exploratory outcome measures such as the Beck Depression Inventory (BDI-II)…

Rx.Health and Wise Therapeutics collaborate to provide game-based digital therapeutic to anxiety patients

(December 15, 2022, NEW YORK) Rx.Health, the leading evidence-based automated care coordination platform, has announced a partnership with Wise Therapeutics, a leading provider of game-based digital therapeutics for mental health. This partnership will enable Rx.Health’s health plan and health system users to deploy Wise’s mobile game to their patient populations as an integrated digital therapeutic for anxiety. Wise Therapeutics has developed

Read More

Wise Therapeutics Announces Healthcare Provider Integrated Deployments to Serve Critical Need for More Accessible Mental Health Treatments

Wise Connect™ Platform offers integrated HIPAA-compliant solution for deployment of digital therapeutics to patients (APRIL 6, 2022, NEW YORK) Wise Therapeutics (Wise), a leading developer of game-based digital therapeutics for mental health, announced new deployments of their digital therapeutics across a variety of healthcare settings, ranging from therapy practices to large health systems. These deployments were enabled by the launch of

Read More

Wise Therapeutics and NYU Langone Health Publish Results of Multiple Sclerosis Study Demonstrating Meaningful Anxiety Reduction Through Game-Based Digital Therapeutic

Leveraging findings from this study and others, Wise is developing Prescription Digital Therapeutics with adaptive, personalized gameplay to address mental health needs in targeted populations like Multiple Sclerosis. (August 11, 2021, NEW YORK) Wise Therapeutics (Wise), a developer of game-based digital therapeutics, announced the results of a study conducted in collaboration with NYU Langone Health, published in Frontiers in Neurology. This clinical trial

Read More

Wise Therapeutics and Soterix Medical Jointly Announce Positive Results of Study Combining Gamified Digital Therapeutics with Neurostimulation Device

Partnership demonstrates how at-home transcranial direct current stimulation (tDCS) can enhance the clinical impact of Wise’s gamified digital therapeutics (June 30, 2021, NEW YORK) Wise Therapeutics (Wise), a developer of game-based digital therapeutics including Personal Zen, and Soterix Medical, a leading manufacturer of wearable tDCS medical devices, jointly announced the results of their collaborative study, published in Frontiers in Neuroergonomics. The study demonstrates how neurostimulation

Read More

Wise Therapeutics Releases Personal Zen to Combat Workplace Stress and Anxiety

Clinically validated game acts as a first line of defense to help employees manage stress and anxiety as we return to hybrid work (May 19, 2021, NEW YORK) — Wise Therapeutics, a leading developer of gamified digital therapeutics, today announced the launch of Personal Zen for Employers; the first and only clinically validated tool to fight stress and anxiety using Attention

Read More

Wise Therapeutics Pursues FDA Clearance for Gamified Prescription Digital Therapeutics Targeting Three Initial Indications

Unmet need, health economic and outcomes impact to be evaluated in advance of lead candidate selection (March 30, 2021, NEW YORK) Wise Therapeutics (Wise), a developer of game-based digital therapeutics such as the mental wellness product Personal Zen, has today announced its intention to pursue FDA clearance across three target indications; alcohol use disorder, multiple sclerosis-related anxiety, and perinatal anxiety. This decision

Read More

Wise Therapeutics Raises Pre-Seed Funding: Releases Free Version of Personal Zen for Android and IoS Free to Consumers

The evidence-based app for stress and anxiety will be widely available to support mental wellness during COVID-19 crisis and beyond (October 8, 2020, New York) Wise Therapeutics, a digital therapeutics company created to improve access to effective mental health treatments using digital interventions, announced the closing of its first outside funding of $525,000 to support Android development and early rollout of

Read More